Probably the most relevant finding of our study was that, in absence of clear vascular remodelling or vasodilatadory endothelial dysfunction, increased levels of endothelium-release biomarkers (sVCAM-1, hs-CRP and TNF-α) were observed in patients with FD. The gene discussed is CRP; the disease is endothelial dysfunction.